AptarGroup appoints Julie Xing as independent director effective March 1, 2023

APTARGROUP, INC.

Julie Xing, 54, appointed to AptarGroup board effective March 1, 2023; term expires at 2023 annual meeting.
Xing is independent under NYSE rules; committee assignments not yet determined.
She serves as Executive Chair of Mundipharma (China) and Board Advisor to Mars; over 20 years in pharma/medtech.
Compensation will match other non-employee directors as described in 2022 proxy statement.
No arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Julie Xing

director

ATR · APTARGROUP, INC.

Effective: 2023-03-01
Filed: March 1, 2023, 6:59 PM ET

On March 1, 2023, the Board of Directors (the “Board”) of AptarGroup, Inc. (the “Company”) appointed Julie Xing as a director effective as of such date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Julie Xing was appointed as director at APTARGROUP, INC..

Action: appointed
Role: director

Exact text from the filing

On March 1, 2023, the Board of Directors (the “Board”) of AptarGroup, Inc. (the “Company”) appointed Julie Xing as a director effective as of such date.

View on SEC.gov

APTARGROUP, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-027439

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.